GlassScriptPhysician profile
Una Clare Miniter
NPI 1073879128
$3,927.61
in general payments reported to CMS, 2019-2025
20 companies · $1,454 in 2025
The $1,454 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2022: $128 · 2023: $1,129 · 2024: $1,093 · 2025: $1,454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,546 · Education: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,545.98 |
| Education | $130.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,207.41 | 2019-2025 | |
| Dermavant Sciences, INC. | $440.75 | 2023-2024 | Vtama |
| Galderma Laboratories, L.P. | $312.19 | 2024-2025 | Nemluvio, Aklief |
| Lilly USA, LLC | $267.27 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Ucb, INC. | $250.00 | 2023-2025 | Bimzelx, Cimzia |
| Genzyme Corporation | $217.52 | 2024-2025 | |
| Janssen Biotech, INC. | $208.67 | 2023-2025 | Tremfya, Simponi Aria, Simponi |
| Incyte Corporation | $191.42 | 2022-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $189.33 | 2025 | Libtayo, Dupixent |
| E.R. Squibb & Sons, L.L.C. | $154.82 | 2023-2025 | Sotyktu |
| Pfizer INC. | $107.08 | 2023-2024 | |
| Amgen INC. | $94.72 | 2023-2025 | Otezla, Otezla |
| Arcutis Biotherapeutics, INC. | $83.28 | 2024 | Zoryve |
| Novartis Pharmaceuticals Corporation | $80.86 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.18 | 2023-2025 | Cyltezo, Spevigo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $20.00 | 2025 | Wegovy |
| Organogenesis INC. | $16.72 | 2023 | Puraply |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.81 | 2022 | |
| Convatec INC. | $15.05 | 2025 | |
| Organon LLC | $6.53 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Una Miniter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.